Status | Study |
Not yet recruiting |
Study Name: Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation Condition: Fluid Loss Symptom Complex, Triple Emergencies Date: 2017-04-25 Interventions: Drug: Lactated Ringer Solution |
Recruiting |
Study Name: 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement Condition: Behcet Disease Date: 2016-03-31 Interventions: Drug: drug administration monthly canakinumab will be administered |
Recruiting |
Study Name: A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients Condition: Intestinal Behcet's Disease (BD) Date: 2016-02-17 |
Recruiting |
Study Name: Uveitis/Intraocular Inflammatory Disease Biobank (iBank) Condition: Uveitis Date: 2016-01-13 |
Not yet recruiting |
Study Name: Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease Condition: Behçet Disease Date: 2015-12-21 Interventions: Drug: Subcutaneous Ustekinumab Injections of ustekinumab at 90 mg at week 0, week 4 and week 16. Patient |
Completed |
Study Name: Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Condition: Behçet's Disease Uveitis Date: 2015-11-26 Interventions: Drug: Intravitreal Infliximab ocular safety and efficacy in treating inflammation in uveitis patients wi |
Recruiting |
Study Name: The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis Condition: Sarcoidosis Tuberculosis Date: 2015-11-26 Interventions: Other: spectrophotometric assay |
Recruiting |
Study Name: Vasculitis Pregnancy Registry Condition: Vasculitis Behcet's Disease C Date: 2015-10-26 Interventions: Other: Online questionnaires Women will be asked to complete questionnaires during their pregnancy and a |
Recruiting |
Study Name: A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Condition: Behcet Disease Date: 2015-06-29 Interventions: Drug: Infliximab Participants will receive infliximab 5 milligram per kilogram (mg/kg) infusion at Week |
Completed |
Study Name: Impact of Vasculitis on Employment and Income Condition: Vasculitis Systemic Vasculitis Behce Date: 2015-06-12 Interventions: Other: online questionnaire The online questionnaire includes questions about vasculitis, employment and |